Plasma total thiol pool in children with asthma: Modulation during montelukast monotherapy


Creative Commons License

DILEK F., Ozkaya E. , Kocyigit A. , Yazici M. , Guler E. M. , DUNDAROZ M. R.

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, vol.29, no.1, pp.84-89, 2016 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 29 Issue: 1
  • Publication Date: 2016
  • Doi Number: 10.1177/0394632015621563
  • Title of Journal : INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
  • Page Numbers: pp.84-89
  • Keywords: asthma, children, montelukast, plasma, TAS, thiol, treatment, OXIDATIVE STRESS, PARAMETERS, ANTAGONIST, PROTEIN, DAMAGE, LUNG

Abstract

Background: Inflammation, which is a hallmark of asthma, is one of the main sources of oxidative stress in the human body. Thiols are powerful antioxidants that protect cells against the consequences of oxidative stress. We aimed to investigate whether asthma and montelukast monotherapy affect the total plasma thiol pool in children.